Voya Financial Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $827K | Sell |
3,778
-112
| -3% | -$24.5K | 0.08% | 113 |
|
|
2025
Q1 | $864K | Buy |
3,890
+210
| +6% | +$46.7K | 0.1% | 103 |
|
|
2024
Q4 | $1.21M | Buy |
3,680
+62
| +2% | +$20.4K | 0.13% | 74 |
|
|
2024
Q3 | $1.13M | Buy |
3,618
+611
| +20% | +$190K | 0.12% | 87 |
|
|
2024
Q2 | $989K | Sell |
3,007
-32
| -1% | -$10.5K | 0.11% | 84 |
|
|
2024
Q1 | $1.2M | Sell |
3,039
-90
| -3% | -$35.5K | 0.14% | 69 |
|
|
2023
Q4 | $1.11M | Buy |
3,129
+2
| +0.1% | +$710 | 0.13% | 68 |
|
|
2023
Q3 | $1.19M | Sell |
3,127
-69
| -2% | -$26.2K | 0.15% | 57 |
|
|
2023
Q2 | $1.21M | Sell |
3,196
-37
| -1% | -$14K | 0.14% | 60 |
|
|
2023
Q1 | $1.1M | Sell |
3,233
-524
| -14% | -$179K | 0.14% | 63 |
|
|
2022
Q4 | $898K | Sell |
3,757
-1,267
| -25% | -$303K | 0.12% | 93 |
|
|
2022
Q3 | $1.26M | Buy |
5,024
+96
| +2% | +$24.1K | 0.16% | 64 |
|
|
2022
Q2 | $1.48M | Sell |
4,928
-62
| -1% | -$18.6K | 0.18% | 54 |
|
|
2022
Q1 | $2.09M | Sell |
4,990
-82
| -2% | -$34.3K | 0.24% | 40 |
|
|
2021
Q4 | $2.39M | Buy |
5,072
+250
| +5% | +$118K | 0.27% | 28 |
|
|
2021
Q3 | $2.09M | Buy |
4,822
+476
| +11% | +$206K | 0.26% | 33 |
|
|
2021
Q2 | $1.57M | Sell |
4,346
-11,468
| -73% | -$4.13M | 0.2% | 43 |
|
|
2021
Q1 | $4.4M | Buy |
15,814
+2,675
| +20% | +$745K | 0.17% | 101 |
|
|
2020
Q4 | $3.68M | Buy |
13,139
+3,622
| +38% | +$1.01M | 0.16% | 107 |
|
|
2020
Q3 | $2.6M | Buy |
9,517
+259
| +3% | +$70.9K | 0.13% | 122 |
|
|
2020
Q2 | $2.04M | Buy |
9,258
+827
| +10% | +$182K | 0.11% | 144 |
|
|
2020
Q1 | $1.28M | Buy |
8,431
+981
| +13% | +$149K | 0.07% | 193 |
|
|
2019
Q4 | $1.12M | Buy |
7,450
+467
| +7% | +$70.5K | 0.06% | 243 |
|
|
2019
Q3 | $984K | Buy |
6,983
+609
| +10% | +$85.8K | 0.05% | 246 |
|
|
2019
Q2 | $788K | Buy |
6,374
+1,399
| +28% | +$173K | 0.04% | 284 |
|
|
2019
Q1 | $535K | Buy |
4,975
+415
| +9% | +$44.6K | 0.03% | 356 |
|
|
2018
Q4 | $439K | Buy |
4,560
+665
| +17% | +$64K | 0.03% | 353 |
|
|
2018
Q3 | $478K | Buy |
3,895
+1,808
| +87% | +$222K | 0.03% | 367 |
|
|
2018
Q2 | $206K | Buy |
+2,087
| New | +$206K | 0.01% | 526 |
|